These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 147131)

  • 21. Mixed beam radiotherapy and combination chemotherapy in localized pancreatic adenocarcinoma-preliminary results.
    Bukowski RM; Gahbauer R; Rodriquez-Antunez A; Hermann R
    Int J Radiat Oncol Biol Phys; 1982 Jul; 8(7):1231-3. PubMed ID: 6214533
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 5 FU infusion with mitomycin-C vs. 5 FU infusion with methyl-CCNU in the treatment of advanced upper gastrointestinal cancer: a Southwest Oncology Group Study.
    Buroker T; Kim PN; Groppe C; McCracken J; O'Bryan R; Panettiere F; Costanzi J; Bottomley R; King GW; Bonnet J; Thigpen T; Whitecar J; Haas C; Vaitkevicius VK; Hoogstraten B; Heilbrun L
    Cancer; 1979 Oct; 44(4):1215-21. PubMed ID: 387204
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clotting activation after blood transfusion in patients receiving 5-fluorouracil and mitomycin-C treatment.
    Agnelli G; Gresele P; Nenci GG
    Cancer Chemother Pharmacol; 1981; 5(3):205-6. PubMed ID: 6794924
    [No Abstract]   [Full Text] [Related]  

  • 24. Combination chemotherapy for islet cell carcinoma and metastatic carcinoid tumors with 5-fluorouracil and streptozotocin.
    Chernicoff D; Bukowski RM; Groppe CW; Hewlett JS
    Cancer Treat Rep; 1979 May; 63(5):795-6. PubMed ID: 222449
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase I trial of ftorafur combined with mitomycin C or methyl-CCNU in gastrointestinal cancers.
    Buroker T; Baker L; Correa J; Schwartz LA; Vailtkevicius VK
    Cancer Treat Rep; 1977; 61(3):463-7. PubMed ID: 326403
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Streptozocin-doxorubicin, streptozocin-fluorouracil or chlorozotocin in the treatment of advanced islet-cell carcinoma.
    Moertel CG; Lefkopoulo M; Lipsitz S; Hahn RG; Klaassen D
    N Engl J Med; 1992 Feb; 326(8):519-23. PubMed ID: 1310159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma. Fluorouracil vs fluorouracil and doxorubicin vs fluorouracil, doxorubicin, and mitomycin.
    Cullinan SA; Moertel CG; Fleming TR; Rubin JR; Krook JE; Everson LK; Windschitl HE; Twito DI; Marschke RF; Foley JF
    JAMA; 1985 Apr; 253(14):2061-7. PubMed ID: 2579257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Chemotherapy for advanced pancreatic carcinoma].
    Yokoyama T; Shimada Y
    Gan To Kagaku Ryoho; 1992 Dec; 19(14):2338-43. PubMed ID: 1463339
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase I study of 7-N-(p-hydroxyphenyl)-mitomycin C.
    Meguro S; Nagata T; Yokoyama K; Chinen T; Yamazaki H; Kobayashi T; Isogai Y; Ogawa M
    Invest New Drugs; 1984; 2(4):381-5. PubMed ID: 6511242
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 5-Fluorouracil, mitomycin, and doxorubicin (FAM) in carcinoma of the biliary tract.
    Harvey JH; Smith FP; Schein PS
    J Clin Oncol; 1984 Nov; 2(11):1245-8. PubMed ID: 6092556
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Results of considerations on the chemotherapy of pancreatic neoplasms].
    Klapdor R
    Med Welt; 1980 Dec; 31(51-52):1853-8. PubMed ID: 6450865
    [No Abstract]   [Full Text] [Related]  

  • 32. [Treatment of advanced pancreatic cancer with 5-fluorouracil, 4-epidoxorubicin and mitomycin C (FEM II). From the Chemotherapy of Gastrointestinal Tumors Group].
    Verhees S; Flechtner H; Queisser W; Heim ME; Fritz M; Trux F; Edler L
    Onkologie; 1990 Feb; 13(1):50-2. PubMed ID: 1692400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase II study of 5-FU, doxorubicin, and mitomycin (FAM) and chlorozotocin in advanced measureable pancreatic cancer.
    Smith FP; Rustgi VK; Schertz G; Woolley PV; Schein PS
    Cancer Treat Rep; 1982 Dec; 66(12):2095-6. PubMed ID: 6215982
    [No Abstract]   [Full Text] [Related]  

  • 34. Chemotherapy of pancreatic carcinoma.
    Zimmerman SE; Smith FP; Schein PS
    Cancer; 1981 Mar; 47(6 Suppl):1724-8. PubMed ID: 6456058
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Chemotherapy of gastrointestinal tumors (review of the literature)].
    Mayr AC
    Onkologie; 1978 Dec; 1(6):248-56. PubMed ID: 83561
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary treatment of regional and disseminated pancreatic cancer with hexamethylmelamine, mitomycin C and 5-fluorouracil infusion.
    Bruckner HW; Kalman J; Spigelman M; Gorbaty MI; Butwell N; Storch J; McKenna A
    Oncology; 1989; 46(6):366-71. PubMed ID: 2511535
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intermittent regional infusion of chemotherapy for pancreatic adenocarcinoma. Phase I and II pilot study.
    Theodors A; Bukowski RM; Hewlett JS; Livingston RB; Weick JK
    Am J Clin Oncol; 1982 Oct; 5(5):555-8. PubMed ID: 6217742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of advanced gastric cancer with 5-fluorouracil versus mitomycin C.
    Gupta S
    J Surg Oncol; 1982 Oct; 21(2):94-6. PubMed ID: 6752585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mitomycin C: experience in the United States, with emphasis on gastric cancer.
    Schein PS; Macdonald JS; Hoth D; Wooley PV
    Cancer Chemother Pharmacol; 1978; 1(2):73-5. PubMed ID: 750107
    [No Abstract]   [Full Text] [Related]  

  • 40. Hyperfractionated radiation and chemotherapy for unresectable localized adenocarcinoma of the pancreas. The Gastrointestinal Tumor Study Group experience.
    Seydel HG; Stablein DM; Leichman LP; Kinzie JJ; Thomas PR
    Cancer; 1990 Apr; 65(7):1478-82. PubMed ID: 2138054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.